High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
SRX Global (AMEX:SRXH) disclosed an investment in Vistagen Therapeutics (NASDAQ:VTGN) and said it intends to engage with the company’s leadership and board on potential shareholder value initiatives. Key Investor TakeawaysSRX Global (AMEX:SRXH) acquired a stake in Vistagen Therapeutics (NASDAQ:VTGN).
With a free cash flow yield of 6.16%, American Express Company (NYSE:AXP) is included among the 12 Stocks From Companies Generating High Cash Flow. On June 15, Reuters reported that American Express Company (NYSE:AXP) had agreed to acquire restaurant reservation platform TheFork from Tripadvisor. The all-cash transaction is valued at $700 million. The sale comes after […]
American Express (NYSE:AXP) agreed to acquire TheFork, Tripadvisor's European restaurant reservation platform, for US$700 million in cash. TheFork operates in 11 European countries and connects users with more than 50,000 restaurants. The deal is expected to close by late 2026, subject to regulatory approvals. American Express (NYSE:AXP) is increasing its focus on dining and experiences, adding TheFork's more than 50,000 European restaurants to its existing network. Once completed, the...
The agreement follows Tripadvisor’s move in February 2026 to explore options for TheFork.
American Express Co. (NYSE:AXP) shares rose 1.
Wall Street looked set to see chipmakers continue their rebound on Tuesday, with investors continuing to pick through the wreckage of last week's tech sell-off ahead of key US inflation data. Futures pointed higher across the board, with contracts on the Nasdaq 100 up 0.9%, S&P 500...
Taking on entrenched offerings from SAP and AmEx, AI-fueled travel and expense tracking platform Navan eyes a buy zone.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.